Innovaccer’s Financials, Revenue, Profit, Valuation & Shareholding Overview (2025)
Legal Name: Innovaccer Analytics Private Limited | CIN: U74140DL2013PTC260365�
Innovaccer, founded in 2014 by Abhinav Shashank, Kanav Hasija, and Sandeep Gupta, is a leading healthtech platform enabling connected care through its data activation platform. Headquartered in Noida and San Francisco, Innovaccer empowers healthcare organizations to unify patient data, improve care delivery, and drive better outcomes. With global...
| Founding year | 2014 |
|---|---|
| Headquarters | Noida, India & San Francisco, USA |
| Valuation | ~$3.2B (2022) |
| Total Funding | $375M |
| Annual Revenue | ₹1,250 Cr (FY24) |
| Annual Net Loss | ₹300 Cr (FY24) |
| EBITDA Margin | -14% |
| Employees | ~1,800 |
| Round | Date | Amount | Investors |
|---|---|---|---|
| Seed | 2015 | $2.5M | Lightspeed Venture Partners |
| Series A | 2016 | $15M | Westbridge, Lightspeed |
| Series B | 2018 | $25M | M12, Westbridge |
| Series C | 2020 | $70M | Tiger Global, Steadview Capital |
| Series D | 2021 | $105M | Dragoneer, Mubadala |
| Series E | 2022 | $157M | OMERS Growth Equity, Tiger Global |
- Expanding partnerships with large healthcare systems across the US.
- Enhancing real-time data insights and population health analytics.
- Integrating AI to streamline workflows and reduce hospital costs.
- Scaling cloud infrastructure for enterprise-grade deployments.
- IPO plans under consideration post FY26 following profitability push.
Innovaccer recently launched a next-gen care intelligence platform focused on streamlining provider operations and improving patient outcomes. With new US-based partnerships and AI enhancements, the company is positioned for major growth in digital health transformation.
| Metric | Detail |
|---|---|
| Revenue Growth | ▲ Strong increase to ₹1,250 Cr in FY24 |
| Profitability | ▼ Net loss of ₹300 Cr |
| Funding | ▲ $375M raised over 6 rounds |
| Efficiency | ▲ EBITDA margin improved to -14% |
| Valuation | ▲ $3.2B as of 2022 |
Innovaccer is at the forefront of healthcare innovation, helping organizations unify data and deliver better care outcomes. Its scalable platform, strong investor backing, and continued expansion in the US market put it on a strategic path toward sustainable growth and potential public listing in the near future.
Make smarter business decisions with verified insights on companies and directors. Visit Affluense.ai to learn more.
- Company filings
- TechCrunch, Inc42, Economic Times
- Affluense.ai internal analytics
This report is generated for informational purposes only and does not constitute investment advice.